Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionPacer Advisors, Inc.
Latest Disclosed Ownership88,863 shares
Latest Disclosed Value $ 39,680,884
Pacer Advisors, Inc. reports 16.71% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 6, 2026 - Pacer Advisors, Inc. filed a 13F-HR form disclosing ownership of 88,863 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $39,680,884 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 24, 2026 disclosing 76,142 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 16.71% during the quarter. The current value of the position is $38,063,577 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 88,863 12,721 16.71 39,681 14.95 0.1023
2026-02-24 2025-12-31 13F/A-1 Vertex Pharmaceuticals Common Stock - Domestic 92532F100 76,142 9,641 14.50 34,520 32.54 0.0882
2026-02-04 2025-12-31 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 76,142 9,641 34,520 0.0472
2025-10-15 2025-09-30 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 66,501 26,543 66.43 26,044 46.41 0.0656
2025-08-12 2025-06-30 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 39,958 9,262 30.17 17,789 19.53 0.0442
2025-05-06 2025-03-31 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 30,696 -8,104 -20.89 14,882 -4.75 0.0348
2025-01-22 2024-12-31 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 38,800 6,359 19.60 15,625 3.56 0.0337
2024-11-12 2024-09-30 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 32,441 -5,885 -15.36 15,088 -16.02 0.0319
2024-08-13 2024-06-30 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 38,326 1,085 2.91 17,964 15.40 0.0407
2024-05-10 2024-03-31 13F Vertex Pharmaceuticals Common Stock - Domestic 92532F100 37,241 -4,011 -9.72 15,567 -7.26 0.0358
2024-01-16 2023-12-31 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 41,252 11,940 40.73 16,785 64.69 0.0475
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 29,312 3,510 13.60 10,193 12.26 0.0390
2023-07-12 2023-06-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 25,802 -11,750 -31.29 9,080 -23.26 0.0366
2023-05-02 2023-03-31 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 37,552 22,887 156.07 11,832 179.43 0.0505
2023-02-06 2022-12-31 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 14,665 4,439 43.41 4,235 42.99 0.0217
2022-10-18 2022-09-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 10,226 61 0.60 2,961 3.39 0.0206
2022-08-12 2022-06-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 10,165 -2,901 -22.20 2,864 -16.01 0.0213
2022-04-05 2022-03-31 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 13,066 -8,387 -39.09 3,410 -27.62 0.0280
2022-02-03 2021-12-31 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 21,453 -7,435 -25.74 4,711 -10.10 0.0483
2021-10-15 2021-09-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 28,888 1,945 7.22 5,240 -3.55 0.0662
2021-07-21 2021-06-30 13F VERTEX PHARMACEUTICALS Common Stock - Domestic 92532F100 26,943 2,820 11.69 5,433 4.80 0.0778
2021-04-05 2021-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 24,123 -2,118 -8.07 5,184 -16.41 0.0901
2021-01-20 2020-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 26,241 -12,246 -31.82 6,202 -40.78 0.1165
2020-10-19 2020-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 38,487 -5,313 -12.13 10,473 -17.64 0.2228
2020-07-29 2020-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 43,800 22,933 109.90 12,716 125.30 0.2575
2020-04-23 2020-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 20,867 611 3.02 5,644 27.26 0.1136
2020-02-10 2019-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 20,256 -26,602 -56.77 4,435 -44.14 0.2004
2019-10-10 2019-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 46,858 5,650 13.71 7,939 5.05 0.1785
2019-08-12 2019-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 41,208 4,058 10.92 7,557 10.58 0.1848
2019-04-10 2019-03-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 37,150 37,150 6,834 0.1896
2019-02-13 2018-12-31 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 0 -25,079 -100.00 0 -100.00
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 25,079 5,052 25.23 4,834 42.05 0.1819
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS Common Stock 92532F100 20,027 3,606 21.96 3,403 27.17 0.1540
2018-05-14 2018-03-31 13F Vertex Pharmaceuticals COM 92532F100 16,421 2,179 15.30 2,676 25.40 0.1480
2018-02-14 2017-12-31 13F Vertex Pharmaceuticals Com 92532F100 14,242 5,904 70.81 2,134 68.30 0.1497
2017-11-08 2017-09-30 13F Vertex Pharmaceuticals Com 92532F100 8,338 1,129 15.66 1,268 36.49 0.1124
2017-08-08 2017-06-30 13F VERTEX PHARMACEUTICALS Com 92532F100 7,209 577 8.70 929 28.14 0.0919
2017-05-09 2017-03-31 13F VERTEX PHARMACEUTICALS Com 92532F100 6,632 310 4.90 725 55.58 0.0889
2017-02-08 2016-12-31 13F VERTEX PHARMACEUTICALS Com 92532F100 6,322 -555 -8.07 466 -22.33 0.0664
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS Com 92532F100 6,877 -280 -3.91 600 -2.60 0.0912
2016-08-12 2016-06-30 13F VERTEX PHARMACEUTICALS Com 92532F100 7,157 -15 -0.21 616 8.07 0.0973
2016-05-13 2016-03-31 13F VERTEX PHARMACEUTICALS Com 92532F100 7,172 248 3.58 570 -34.56 0.1293
2016-02-17 2015-12-31 13F VERTEX PHARMACEUTICALS Com 92532F100 6,924 6,924 871 0.2046
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.